Navigation Links
Assured Pharmacy Reports Results for the Fiscal Year 2011

FRISCO, Texas, April 4, 2012 /PRNewswire/ -- Assured Pharmacy (APHY: pinksheets), a leading specialty pharmacy group providing prescription medications to sufferers of chronic pain, announced net sales of $16,444,573 for the year ended December 31, 2011, an increase of $167,821 or 1.0%, from $16,276,752 for the year ended December 31, 2010.  Basic and diluted net loss per share was $1.14 for the year 2011, a 54.0% improvement compared to $2.48 net loss per share in the same period in 2010.

The increase in sales for the year 2011 compared to the year 2010 was primarily due to an increase in the number of patients serviced as a result of our continued direct sales efforts and to a much lesser extent the opening of our 5th pharmacy in the Kansas City metropolitan area in November 2011.  The increase in revenue from increased patients was partially offset by a decrease in revenue per prescription due to increased generic utilization by our patients and to a lesser extent a decrease in management service fee revenue of $160,005.  As a result of the increase in generic utilization, our gross profit margins on pharmacy revenue increased to 19.1% for the year 2011 up from 17.6% for the year 2010. The number of prescriptions filled by our pharmacies increased by 6,300 prescriptions or 5.7%, with 117,410 prescriptions filled in the year ended December 31, 2011, as compared to 111,110 prescriptions filled in the year 2010.We are pleased with the year over year performance improvement in our operations for the year 2011 and the opening our new pharmacy in Kansas.  The opening of our new pharmacy and improved operating results reflect continued progress in the implementation of our strategies and provide further validation of our business model as we move forward with the expansion of our business," said Robert DelVecchio, Chief Executive Officer of Assured Pharmacy. 

The audited financial statements for the years ended December 31, 2011, and 2010 have been posted on the OTC Markets website and are available at under our trading symbol, APHY.

About Assured Pharmacy, Inc.Assured Pharmacy, Inc. is a growing provider of specialty pharmacy services to patients and physicians in the treatment of chronic pain.  Through its network of specialty pharmacies, the Company predominantly dispenses highly regulate pain mediations to sufferers of chronic pain, while stringently adhering to federal and state reporting requirements for both patients and physicians.  The Company derives its revenue primarily from the sale of prescription drugs and does not keep in inventory non-prescription drugs or health and beauty related products inventoried at traditional pharmacies. The majority of the Company's business is derived from repeat visits from its customer base of physician-referred chronic pain patients. "Walk-in" prescriptions from physicians are limited. The Company currently has five operating pharmacies which are wholly owned including its fifth operating pharmacy in the Kansas City metropolitan area which opened in November 2011.

Safe Harbor StatementThis press release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Act of 1934.
These forward-looking statements are based largely on the expectations or forecasts of future events, can be affected by inaccurate assumptions, and are subject to various business risks and known and unknown uncertainties, a number of which are beyond the control of management.
Therefore, actual results could differ materially from the forward-looking statements contained in this press release.
A wide variety of factors that may cause actual results to differ from the forward-looking statements include, but are not limited to, the following: the Company's ability to increase revenue and profits in the current economic climate; the effect of changing economic conditions; lack of sufficient financing for opening new pharmacies; inability to manage growth; and changes in government regulations, controls and similar matters.
These cautionary statements should not be construed as exhaustive or as any admission as to the adequacy of the Company's disclosures.
The Company cannot predict or determine after the fact what factors would cause actual results to differ materially from those indicated by the forward-looking statements or other statements.
The reader should consider statements that include the words "believes," "expects," "anticipates," "intends," "estimates," "plans," "projects," "should," or other expressions that are predictions of or indicate future events or trends, to be uncertain and forward-looking.
The Company does not undertake to publicly update or revise forward-looking statements, whether as a result of new information, future events or otherwise.Investor Contact: 

Erika Moran/Adam Holdsworth

The Investor Relations Group

11 Stone St. 3rd Floor

New York, NY


SOURCE Assured Pharmacy, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Assured Pharmacy to Present at Andas 2012 Supply Chain Symposium
2. Assured Pharmacy, Inc. Receives Gross Proceeds of $740,000 from Sale of Convertible Debentures and Warrants
3. Assured Pharmacy Reports Financial Results for the Third Quarter of 2011
4. Assured Pharmacy, Inc. Receives Gross Proceeds of $400,000 from Sale of Convertible Debentures and Warrants
5. Assured Pharmacy Signs Lease in Kansas City, Kansas for its Fifth Pharmacy Location
6. Assured Pharmacy Upgrades to OTC Pink Current Information
7. Assured Pharmacy Engages The Investor Relations Group
8. Assured Pharmacy, Inc. Receives Gross Proceeds of $200,000 from Sale of Convertible Debentures and Warrants
9. Assured Pharmacy Completes Audit of 2010 Financial Statements
10. Assured Pharmacy Announces Reverse Stock Split
11. Assured Pharmacy Reports Same Store Sales for the Month of January 2011
Post Your Comments:
(Date:6/24/2016)... 2016 According to a new ... Pen Needles, Safety Pen Needles), Needle Length (4mm, 5mm, ... Mode of Purchase (Retail, Non-Retail) - Trends & Global ... the market for the forecast period of 2016 to ... Billion by 2021 from USD 1.65 Billion in 2016, ...
(Date:6/24/2016)... Belgium , June 24, 2016 ... today announced the appointment of Dr. Edward ... as a Non-Executive Director, effective June 23, 2016.Dr. ... Compensation and Nominations and Governance Committees.  As a ... will provide independent expertise and strategic counsel to ...
(Date:6/23/2016)... 2016  MedSource announced today that it has ... solution of choice.  This latest decision demonstrates MedSource,s ... their clients by offering a state-of-the-art electronic data ... nowEDC as the EDC platform of choice in ... "nowEDC has long been a preferred EDC platform ...
Breaking Medicine Technology:
(Date:6/25/2016)... ... June 25, 2016 , ... On Friday, June 10, Van Mitchell, Secretary of ... award to iHire in recognition of their exemplary accomplishments in worksite health promotion. , ... Workplace Health & Wellness Symposium at the BWI Marriott in Linthicum Heights. iHire was ...
(Date:6/24/2016)... Michigan (PRWEB) , ... June 24, 2016 , ... June ... about the dangers associated with chronic pain and the benefits of holistic treatments, ... individuals who are suffering with Sickle Cell Disease. , Sickle Cell Disease (SCD) is ...
(Date:6/24/2016)... (PRWEB) , ... June 24, 2016 , ... ... now offering micro-osteoperforation for accelerated orthodontic treatment. Dr. Cheng has extensive experience with ... Damon brackets , AcceleDent, and accelerated osteogenic orthodontics. , Micro-osteoperforation is a ...
(Date:6/24/2016)... ... June 24, 2016 , ... ... Clinical Decision Making in Emergency Medicine conference in Ponte Vedra Beach, FL. The ... published in Emergency Medicine Practice and Pediatric Emergency Medicine Practice. , ...
(Date:6/24/2016)... ... June 24, 2016 , ... National recruitment firm Slone Partners ... extensive sequencing and genomics experience, as Vice President of North American Capital Sales at ... responsible for leading the sales team in the commercialization of the HTG EdgeSeq system ...
Breaking Medicine News(10 mins):